Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kingfisher International is a specialized contract research organization (CRO) and supplier of research models for the global biomedical and veterinary sectors. Based in the United Kingdom, the company provides high-quality, specific pathogen-free (SPF) animals, including ferrets, pigs, and sheep, which are essential for preclinical research and vaccine development. Their services encompass a wide range of contract research capabilities, such as efficacy and safety testing, pharmacokinetic studies, and regulatory-compliant clinical trials for animal health products. Kingfisher International is particularly recognized for its expertise in respiratory and infectious disease models, supporting the development of human and animal vaccines. The company operates state-of-the-art facilities that adhere to stringent animal welfare and regulatory standards, ensuring reliable data for its pharmaceutical and biotechnology clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kingfisher International Biomedical.